1. Introduction {#sec1-molecules-21-00462}
===============

In recent years, 3,4-dihydropyrimidin-2(1*H*)-ones (DHPMs) and their derivatives have received much attention because they are important substructures in both biologically active compounds and several marine alkaloids involving the DHPM core units \[[@B1-molecules-21-00462]\]. A simple and direct approach for their synthesis involves the conjugate addition of aryl aldehyde, β-ketoester and urea in the presence of either protic or Lewis acids. In recent years, several improved methods have been reported for the preparation of these compounds using various catalysts such as *p*-TsOH·H~2~O \[[@B2-molecules-21-00462]\], H~3~BO~3~ \[[@B3-molecules-21-00462]\], \[Al(H~2~O)~6~\](BF~4~)~3~ \[[@B4-molecules-21-00462]\], thiamine hydrochloride \[[@B5-molecules-21-00462]\], [l]{.smallcaps}-(+)-tartaric acid-dimethylurea \[[@B6-molecules-21-00462]\], imidazole-1--yl-acetic acid \[[@B7-molecules-21-00462]\], HClO~4~-SiO~2~ \[[@B8-molecules-21-00462]\], polyvinylsulfonic acid \[[@B9-molecules-21-00462]\], SnCl~2~·2H~2~O \[[@B10-molecules-21-00462]\], NaCl \[[@B11-molecules-21-00462]\], SrCl~2~·6H~2~O \[[@B12-molecules-21-00462]\], Al-planted MCM-41 \[[@B13-molecules-21-00462]\], (NH~4~)~2~CO~3~ \[[@B14-molecules-21-00462]\], CeCl~3~·7H~2~O \[[@B15-molecules-21-00462]\], CaCl~2~ \[[@B16-molecules-21-00462]\], Ce(NH~4~)~2~(NO~3~)~6~ \[[@B17-molecules-21-00462]\] and Fe(OTs)~3~·6H~2~O \[[@B18-molecules-21-00462]\]. However, several of these reported procedures suffer from some drawbacks such as strong acidic conditions, long reaction times, use of expensive or hazardous reagents, complex handling and low yields of products. Moreover, most of these methods employ organic solvents as the reaction medium. Hence, new, efficient and environmentally friendly procedures are still strongly demanded in organic transformations such as condensation reactions.

Currently, ionic liquids (ILs) have been widely used as environmentally benign reaction media and catalysts in organic synthesis owing to their unique properties of non-volatility, excellent solubility, high thermal stability and recyclability \[[@B19-molecules-21-00462],[@B20-molecules-21-00462]\]. In particular, the synthesis of task-specific ILs (TSIL) with special functions according to the requirement of a specific reaction has become an attractive field. Extensive effort has been focused on the elucidation of the mechanism of Lewis acid--catalyzed Biginelli reactions in ionic liquids \[[@B21-molecules-21-00462]\]. Sharma *et al.* \[[@B22-molecules-21-00462]\] reported highly recyclable amino acid ionic liquids as a catalyst, particularly glycine nitrate, for the one-pot, three-component Biginelli condensation under microwave irradiation (MW). Recently, Kandasamy and co-workers realized the synthesis of 1-alkyl triazolium triﬂate room temperature ionic liquids and their catalytic studies in a multi-component Biginelli reaction \[[@B23-molecules-21-00462]\]. In continuation of our interest in the Biginelli reaction \[[@B24-molecules-21-00462],[@B25-molecules-21-00462],[@B26-molecules-21-00462]\], herein we employ Brønsted acid ionic liquid 1-butyl-3-carboxymethyl-benzotriazolium trifluoroacetate \[C~2~O~2~BBTA\]\[TFA\] as a catalyst to study the possibility of synthesizing DHPMs under solvent-free conditions ([Scheme 1](#molecules-21-00462-sch001){ref-type="scheme"}).

2. Results and Discussion {#sec2-molecules-21-00462}
=========================

The catalytic activity of \[C~2~O~2~BBTA\]\[TFA\] was investigated in a one-pot Biginelli condensation of aryl aldehyde, β-ketoester and urea. The results are presented in [Table 1](#molecules-21-00462-t001){ref-type="table"}. The best result was achieved by carrying out the reaction at 90 °C for 40 min in the presence of 10% catalytic amount of \[C~2~O~2~BBTA\]\[TFA\] without any solvent ([Table 1](#molecules-21-00462-t001){ref-type="table"}, entry **8**). Inspired by Clark's work \[[@B27-molecules-21-00462]\], we explored the relationship between the catalyst and solvents ([Table 1](#molecules-21-00462-t001){ref-type="table"}, entries **1**--**8**). When molecular solvents, such as H~2~O, MeOH, CH~3~CN or toluene, were employed, the reaction afforded a mixture of benzaldehyde, ethyl acetoacetate and urea under similar conditions, and DHPMs were obtained only in a very low yield (\<19%). When no catalyst was used in this reaction system, the reaction did not give the desired product. This showed that ionic liquid plays a very important role in the reaction system ([Table 1](#molecules-21-00462-t001){ref-type="table"}, entry **9**). The influence of the reaction time on the yield was also investigated as shown in [Table 1](#molecules-21-00462-t001){ref-type="table"}, entries **8**, 15--19. It turned out that although the reaction time was increased to 40 min, the yield did not change significantly ([Table 1](#molecules-21-00462-t001){ref-type="table"}, entry **8**). For the purpose of saving energy, we chose 40 min as the reaction time. Hence, the best conditions employed a 0.1:2:2:3 mole ratio of \[C~2~O~2~BBTA\]\[TFA\], aryl aldehyde, β-ketoester, and urea at 90 °C for 40 min under solvent-free conditions.

The recycling performance of TSIL \[C~2~O~2~BBTA\]\[TFA\] was one of its most important benefits, which was also investigated in the reaction of aryl aldehyde, β-ketoester and urea. After separation of the product, the filtrate containing catalyst was vacuumed to remove water and the resulting catalyst was reused directly for the next run. As shown in [Table 1](#molecules-21-00462-t001){ref-type="table"}, Brønsted acidic ionic liquid \[C~2~O~2~BBTA\]\[TFA\] can be recycled at least six times without showing a significant decrease in catalytic activity, and the yields ranged from 96% to 92% ([Table 1](#molecules-21-00462-t001){ref-type="table"}, entry **8**). This indicated that ionic liquid \[C~2~O~2~BBTA\]\[TFA\] was an eﬃcient and recyclable catalyst for the preparation of 3,4-dihydropyrimidin-2(1*H*)-ones derivatives.

In order to explore the scope and limitations of this reaction, we extended the procedure to various aryl-substituted aldehydes carrying either electron-donating or -withdrawing groups in the *ortho*, *meta*, and *para* positions. In general, the reaction proceeded easily under the best conditions and the adducts were isolated in excellent yields and high purity. In addition, compared to the reported synthetic method of 6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate ([Table 2](#molecules-21-00462-t002){ref-type="table"}, entry **3a**) by using HCl as a catalyst and ethonal as a solvent \[[@B28-molecules-21-00462]\], our strategy has the advantages of higher yield (96% *vs.* 78%) and shorter reaction time (40 min *vs.* 3 h). The obtained results indicated that the electron-donating or -withdrawing groups at the aryl ring did not seem to affect the reaction significantly in terms of yield ([Table 2](#molecules-21-00462-t002){ref-type="table"}, entries **3a**--**3o**). Thiourea has been used with similar success to provide the corresponding *S*-dihydropyrimidinones analogues, which are also of interest due to their biological activities ([Table 2](#molecules-21-00462-t002){ref-type="table"}, entries **3p**--**3t**). The use of different substituted β-ketoester as a 1,3-dicarbonyl moiety in place of ethyl acetoacetate also gave similar results, as shown in [Table 2](#molecules-21-00462-t002){ref-type="table"} (entries **3u**--**3ab**).

3. Experimental Section {#sec3-molecules-21-00462}
=======================

All melting points were determined using a Büchi B-540 instrument. All melting points are uncorrected. All new compounds were characterized by IR, ^1^H- and ^13^C-NMR spectra. The IR spectra were obtained as potassium bromide pellets with a FTS-40 spectrometer (BIO-RAD, Hercules, CA, USA). The ^1^H-NMR spectra were measured on a Varian Inova-400 spectrometer (at 400 and 100 MHz, respectively) using TMS as an internal standard in CDCl~3~ or DMSO-*d*~6~.

3.1. General Procedure for the Synthesis of 1-Butyl-3-carboxymethyl-benzotriazolium Trifluoroacetate {#sec3dot1-molecules-21-00462}
----------------------------------------------------------------------------------------------------

\[C~2~O~2~BBTA\]\[TFA\]: benzotriazole (0.2 mol) and chlorobutane (0.24 mol) were dissolved in 30% aqueous solution of sodium hydroxide (100 mL). Tetrabutylammonium bromide (1 g) was added and the solution was stirred 24 h at 80 °C until two phases formed. The top organic phase and bottom water phase were separated with separating funnel. Any remaining water in the organic phase was removed by decompressing Ratovapor at 70 °C \[[@B46-molecules-21-00462]\]. The 1-butylbenzotriazole (0.1 mol) and chloroacetic acid (0.1 mol) were added to a 50 mL round bottom flask fitted with a reﬂux condenser. The solution was stirred for 36 h at 90 °C. Then the mixture was washed at least three times with diethyl ether and acetone. The product (\[C~2~O~2~BBTA\]\[Cl\]) precipitated as a white solid and then was collected by filtration and dried *in vacuo* for 24 h. The \[C~2~O~2~BBTA\]\[Cl\] (0.05 mol) was transferred to a 25 mL round bottom flask and trifluoroacetic acid (TFA, 0.06 mol) was added dropwise, then stirred 24 h at 80 °C. Finally, any remaining TFA was removed by decompressing Ratovapor at 90 °C for 1 h and dried *in vacuo* for 24 h ([Scheme 2](#molecules-21-00462-sch002){ref-type="scheme"}).

3.2. General Procedure for the Synthesis of 3,4-Dihydropyrimidin-2(1H)-(thio)ones {#sec3dot2-molecules-21-00462}
---------------------------------------------------------------------------------

A mixture of aryl aldehyde (2 mmol), β-ketoester (2 mmol), urea (2 mmol) and \[C~2~O~2~BBTA\]\[TFA\] (0.2 mmol) were heated at 90 °C under solvent-free conditions for 40 min with stirring ([Scheme 1](#molecules-21-00462-sch001){ref-type="scheme"}). After cooling, the reaction mixture was poured onto crushed ice (30 g) and stirred for 10 min. The separated solid was filtered under suction, washed with cold water (30 mL) and then recrystallized from ethanol to afford the pure product. The resulting precipitate was filtered under suction. The results are summarized in [Table 2](#molecules-21-00462-t002){ref-type="table"}. All products (except **3l**--**3m**, **3y**--**3ab**) are known compounds, which were characterized by IR, ^1^H and ^13^C-NMR spectra.

*1-Butyl-3-carboxymethyl-benzotriazolium Trifluoroacetate* \[C~2~O~2~BBTA\]\[TFA\]: brown liquid; ^1^H-NMR (DMSO-*d*~6~, 400 MHz, TMS): δ 0.93 (t, 3H, CH~3~), 1.31--1.41 (m, 2H, CH~2~), 2.00--2.07 (m, 2H, CH~2~), 5.11 (t, 2H, CH~2~), 6.13 (s, 2H, CH~2~), 8.00--8.53 (m, 4H, Ar-H); ^13^C-NMR (DMSO-*d*~6~, 100 MHz, ppm): δ 166.4, 158.3 (q, COCF~3~), 135.0, 134.3, 131.4, 130.9, 115.6 (q, CF~3~), 114.1, 114.0, 51.9, 51.2, 30.2, 18.7, 13.0 ppm; IR (KBr, ν/cm^−1^): 3106, 2967, 2940, 2879, 2511, 1738, 1505, 1471, 1364, 1190, 1141, 1029, 754, 718, 643, 599; ESI-MS: *m/z* (%) = 234.1 (100) \[M\]^+^, 113.0 (100) \[M\]^−^.

*5-Ethoxycarbonyl-6-methyl-4-(2-chloro-4-fluorophenyl)-3,4-dihydropyrimidin-2(1H)-thione* (**3l**): white solid; 1H-NMR (400 MHz, DMSO-*d*~6~), δ: 1.00 (t, 3H, OCH~2~CH~3~), 2.29 (s, 3H, CH~3~ ), 3.89 (q, 2H, OCH~2~), 5.59 (s, 1H, CH), 7.20 (t, 1H, Ar-H), 7.32--7.39 (dd, 2H, Ar-H), 7.73 (s, 1H, NH), 9.30 (s, 1H, NH); ^13^C-NMR (100 MHz, DMSO-*d*~6~), δ: 13.80, 17.56, 39.07, 39.59, 50.90, 58.98, 97.61, 115.53, 131,26, 138.24, 138.27, 149.28, 151.08, 159,52, 162.98, 164.74; IR (KBr, ν/cm^−1^): 3346, 3225, 3112, 2976, 1697, 1644, 1223, 1093, 903, 805.

*5-Ethoxycarbonyl-6-methyl-4-(3-bromo-4-fluorophenyl)-3,4-dihydropyrimidin-2(1H)-thione* (**3y**): white solid; 1H-NMR (400 MHz, DMSO-*d*~6~), δ: 1.09 (t, 3H, OCH~2~CH~3~), 2.25 (s, 3H, CH~3~ ), 3.99 (q, 2H, OCH~2~), 5.15 (s, 1H, CH), 7.24--7.27 (m, 1H, Ar-H), 7.33--7.37 (t, 1H, Ar-H), 7.48--7.50 (dd, 1H, Ar-H), 7.79 (s, 1H, NH), 9.29 (s, 1H, NH); ^13^C-NMR (100 MHz, DMSO-*d*~6~), δ: 13.92, 17.72, 52.97, 59.20, 98.41, 112.13, 127.44, 131.19,142.88, 148.95, 151.66, 156.05, 158.49, 164.99; IR (KBr, ν/cm^−1^): 3342, 3203, 3100, 2984, 1702, 1658, 1232, 1099, 895, 804.

*5-Isopropoxycarbonyl-6-methyl-4-(3-methoxyphenyl)-3,4-dihydropyrimidin-2(1H)-thione* (**3z**): white solid; 1H-NMR (400 MHz, DMSO-*d*~6~), δ: 1.01 (d, 3H, CH3), 1.16 (d, 3H, CH~3~CH), 2.23 (s, 3H, CH~3~C), 3.72 (s, 3H, MeO), 4.82 (m, 1H, CHCH~3~), 5.10 (s, 1H, CH), 6.76--6.83 (m, 3H, Ar-H), 7.24 (t, H, Ar-H), 7.70 (s, 1H, NH), 9.15 (s, 1H, NH); ^13^C-NMR (100 MHz, DMSO-*d*~6~), δ: 17.60, 21.54, 53.73, 54.86, 66.24, 99.34, 112.16, 118.19, 129.37, 146.34, 148.05, 152.07, 159.07, 164.73; IR (KBr, ν/cm^−1^): 3234, 3106, 2981, 2948, 1721, 1652, 1599, 1463, 1431, 1374, 1282, 1232, 1092, 1073, 788.

*5-Isopropoxycarbonyl-6-methyl-4-(4-hydroxyphenyl)-3,4-dihydropyrimidin-2(1H)-thione* (**3z**): orange solid; 1H-NMR (400 MHz, DMSO-*d*~6~), δ: 1.00 (d, 3H, CH3), 1.15 (d, 3H, CH~3~CH), 2.22 (s, 3H, CH~3~C), 4.80 (m, 1H, CHCH~3~), 5.02 (s, 1H, CH), 6.68 (d, 2H, Ar-H), 7.02 (d, 2H, Ar-H), 9.07 (s, 1H, NH), 9.31 (s, 1H, OH); ^13^C-NMR (100 MHz, DMSO-*d*~6~), δ: 17.56, 21.39, 21.69, 53.44, 66.09, 99.91, 114.79, 114.79, 127.35, 127.35, 135.46, 147.35, 152.02, 156.39, 164.79; IR (KBr, ν/cm^−1^): 3289, 3227, 3109, 2979, 2808, 1706, 1686, 1651, 1511, 1448, 1371, 1282, 1226, 1173, 1086, 783, 680.

*5-Tert-Butoxycarbonyl-6-methyl-4-(4-fluorophenyl)-3,4-dihydropyrimidin-2(1H)-thione* (**3aa**): faint yellow solid; 1H-NMR (400 MHz, DMSO-*d*~6~), δ: 1.28 (s, 9H, (CH~3~)~3~C), 2.21 (s, 3H, CH~3~C), 5.07 (s, 1H, CH), 7.13--7.18 (m, 2H, Ar-H), 7.22--7.26 (m, 2H, Ar-H), 7.66 (s, 1H, NH), 9.09 (s, 1H, NH); ^13^C-NMR (100 MHz, DMSO-*d*~6~), δ: 17.56, 27.72, 27.72, 53.60, 79.09, 100.25, 114.92, 128.12, 128.20, 141.12, 141.15, 147.43, 151.81, 159.96, 162.38, 164.61; IR (KBr, ν/cm^−1^): 3230, 3107, 2975, 2930, 1697, 1644, 1507, 1452, 1366, 1292, 1230, 1164, 1090, 1035, 837, 798, 759, 658.

*5-Tert-Butoxycarbonyl-6-methyl-4-(3-methoxyphenyl)-3,4-dihydropyrimidin-2(1H)-thione* (**3ab**): faint yellow solid; 1H-NMR (400 MHz, DMSO-*d*~6~), δ: 1.29 (s, 9H, (CH~3~)~3~C), 2.21 (s, 3H, CH~3~C), 2.27 (s, 3H, CH~3~C), 5.07 (s, 1H, CH), 7.01--7.06 (m, 3H, Ar-H), 7.18--7.22 (t, 1H, Ar-H), 7.63 (s, 1H, NH), 9.05 (s, 1H, NH); ^13^C-NMR (100 MHz, DMSO-*d*~6~), δ: 17.56, 21.01, 27.72, 27.72, 27.72, 54.20, 78.99, 100.50, 123.22, 126.79, 127.67, 128.12, 137.07, 144.89, 147.04, 152.05, 164.73; IR (KBr, ν/cm^−1^): 3226, 3099, 2977, 2935, 1699, 1647, 1489, 1438, 1366, 1294, 1232, 1165, 1087, 859, 813, 774, 745, 697, 670, 599.

4. Conclusions {#sec4-molecules-21-00462}
==============

In summary, we have reported an efficient and convenient method for the synthesis of a series of novel dihydropyrimidin-2(1*H*)-ones using aryl aldehyde, β-ketoester and urea as substrates and employing Brønsted acidic ionic liquid \[C~2~O~2~BBTA\]\[TFA\] as a catalyst. This method offers several advantages including high yields, short reaction times, and a simple work-up procedure. It also has the ability to tolerate a wide variety of substituted groups in all three components, which is lacking in existing procedures.
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![Condensation of aryl aldehyde, β-ketoester and urea in the presence of \[C~2~O~2~BBTA\]\[TFA\].](molecules-21-00462-sch001){#molecules-21-00462-sch001}

![Synthesis of \[C~2~O~2~BBTA\]\[TFA\].](molecules-21-00462-sch002){#molecules-21-00462-sch002}

molecules-21-00462-t001_Table 1

###### 

Effect of catalyst \[C~2~O~2~BBTA\]\[TFA\] under different conditions for the reaction of aryl aldehyde, β-ketoester and urea ^a^.

  Entry       Solvent        IL (mol %)   Time (min)   Yield (%) ^b^
  ----------- -------------- ------------ ------------ ------------------------
  **1**       H~2~O          10           40           5
  **2**       MeOH           10           40           3
  **3**       EtOH           10           40           10
  **4**       CH~2~Cl~2~     10           40           16
  **5**       CH~3~CN        10           40           19
  **6**       DMF            10           40           NR
  **7**       Toluene        10           40           5
  **8 ^c^**   solvent-free   10           40           96, 95, 95, 94, 93, 92
  **9**       solvent-free   None         40           NR
  **10**      solvent-free   1            40           81
  **11**      solvent-free   2.5          40           84
  **12**      solvent-free   5            40           85
  **13**      solvent-free   15           40           95
  **14**      solvent-free   20           40           93
  **15**      solvent-free   10           10           75
  **16**      solvent-free   10           20           91
  **17**      solvent-free   10           30           94
  **18**      solvent-free   10           50           91
  **19**      solvent-free   10           60           93

^a^ Reaction conditions: benzaldehyde (2 mmol), ethyl acetoacetate (2 mmol), urea (3 mmol) and catalyst in solvent (5 mL) or solvent-free, 90 °C; ^b^ Isolated yield; ^c^ catalyst was recycled six times.

molecules-21-00462-t002_Table 2

###### 

The \[C~2~O~2~BBTA\]\[TFA\]-catalyzed synthesis of 3,4-dihydropyrimidin-2(1*H*)-ones ^a^.

  Entry     R1                       R2        X   Yields ^b^ (%)   Mp (°C) ^c^   
  --------- ------------------------ --------- --- ---------------- ------------- ----------------------------------------
  **3a**    C~6~H~5~                 EtO       O   96               201--202      200--202 \[[@B29-molecules-21-00462]\]
  **3b**    2-F-C~6~H~4~             EtO       O   96               236--237      235--237 \[[@B30-molecules-21-00462]\]
  **3c**    3-F-C~6~H~4~             EtO       O   97               209--211      209--211 \[[@B31-molecules-21-00462]\]
  **3d**    4-F-C~6~H~4~             EtO       O   98               175--176      175--177 \[[@B32-molecules-21-00462]\]
  **3e**    2-Cl-C~6~H~4~            EtO       O   93               211--213      211--213 \[[@B33-molecules-21-00462]\]
  **3f**    2-Br-C~6~H~4~            EtO       O   93               204--205      205--207 \[[@B30-molecules-21-00462]\]
  **3g**    3-Br-C~6~H~4~            EtO       O   94               190--191      190--192 \[[@B26-molecules-21-00462]\]
  **3h**    3-Me-C~6~H~4~            EtO       O   92               228--230      228--230 \[[@B34-molecules-21-00462]\]
  **3i**    4-Me-C~6~H~4~            EtO       O   97               209--211      209--212 \[[@B35-molecules-21-00462]\]
  **3j**    3,4-(MeO)~2~-C~6~H~3~    EtO       O   98               171--172      172--174 \[[@B36-molecules-21-00462]\]
  **3k**    3-MeO-C~6~H~4~           EtO       O   93               219--221      219--220 \[[@B37-molecules-21-00462]\]
  **3l**    2-Cl-4-F-C~6~H~3~        EtO       O   88               195--197      
  **3m**    3-Br-4-F-C~6~H~3~        EtO       O   85               193--195      
  **3n**    3,4-(HO)~2~-C~6~H~3~     EtO       O   89               232--234      233--235 \[[@B37-molecules-21-00462]\]
  **3o**    4-N(CH~3~)~2~-C~6~H~4~   EtO       O   89               249--251      249--250 \[[@B38-molecules-21-00462]\]
  **3p**    C~6~H~5~                 EtO       S   83               202--204      202--204 \[[@B39-molecules-21-00462]\]
  **3q**    4-F-C~6~H~4~             EtO       S   86               192--193      191--192 \[[@B40-molecules-21-00462]\]
  **3r**    3-Me-C~6~H~4~            EtO       S   86               193--195      194--195 \[[@B41-molecules-21-00462]\]
  **3s**    4-Me-C~6~H~4~            EtO       S   90               184--186      185--186 \[[@B42-molecules-21-00462]\]
  **3t**    3-MeO-C~6~H~4~           EtO       S   93               140--142      141--143 \[[@B37-molecules-21-00462]\]
  **3u**    4-F-C~6~H~4~             MeO       O   98               188--189      188--190 \[[@B43-molecules-21-00462]\]
  **3v**    4-Me-C~6~H~4~            MeO       O   96               202--203      202--204 \[[@B44-molecules-21-00462]\]
  **3w**    3-MeO-C~6~H~4~           MeO       O   92               206--208      204--206 \[[@B29-molecules-21-00462]\]
  **3x**    4-OH-C~6~H~4~            MeO       O   99               231--233      231--233 \[[@B45-molecules-21-00462]\]
  **3y**    3-MeO-C~6~H~4~           *i*-PrO   O   94               196--198      
  **3z**    4-OH-C~6~H~4~            *i*-PrO   O   98               192--194      
  **3aa**   4-F-C~6~H~4~             *t*-BuO   O   99               147--149      
  **3ab**   3-MeO-C~6~H~4~           *t*-BuO   O   95               212--214      

^a^ Reaction conditions: benzaldehyde (2 mmol), ethyl acetoacetate (2 mmol), urea (3 mmol) and catalyst in solvent-free, 90 °C; ^b^ Isolated yield; ^c^ Melting points are uncorrected.

[^1]: The two authors contributed equally to this paper.
